Skip to main content
. 2021 Aug 18;9(1):10.1128/spectrum.00550-21. doi: 10.1128/spectrum.00550-21

FIG 2.

FIG 2

The actuarial probability of 30-day attributable mortality in patients with bloodstream infections (BSIs) according to strong biofilm producers (SBPs) versus weak biofilm producers (WBPs).